Oncology Impact Fund (Cayman) Management L.P.
CIK 1721036 · last filed 2025-11-25
Oncology Impact Fund (Cayman) Management L.P. is a corporate insider who has filed 10 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing shows the insider sold $1.3M of HOWL on Nov 25, 2025. Across all open-market trades the lifetime net is −$69.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.95M
3
10
-$69.30M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HOWL | 10%+ Owner | 5,125,770 | $0.38 | $1.95M | -$4.36M | 3 | 2025-11-25 |
| iTeos Therapeutics, Inc. (ITOS) Delisted | 10%+ Owner | 3,452,797 | $10.15 | $35.05M | -$51.02M | 3 | 2025-05-15 |
| Harpoon Therapeutics, Inc. (HARP) Delisted | 10%+ Owner | 6,399,550 | $23.01 | $147.25M | -$13.92M | 4 | 2021-05-27 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-25 | HOWL | Sell (S) | −1,369,662 | -$1.26M | EDGAR |
| 2025-11-20 | HOWL | Sell (S) | −1,120,721 | -$1.04M | EDGAR |
| 2025-11-06 | HOWL | Sell (S) | −1,700,230 | -$2.07M | EDGAR |
| 2025-05-15 | iTeos Therapeutics, Inc. (ITOS) Delisted | Sell (S) | −4,127,724 | -$33.27M | EDGAR |
| 2021-10-12 | iTeos Therapeutics, Inc. (ITOS) Delisted | Sell (S) | −348,024 | -$9.48M | EDGAR |
| 2021-09-08 | iTeos Therapeutics, Inc. (ITOS) Delisted | Mixed | −410,288 | -$8.27M | EDGAR |
| 2021-05-27 | Harpoon Therapeutics, Inc. (HARP) Delisted | Sell (S) | −85,795 | -$1.73M | EDGAR |
| 2021-05-20 | Harpoon Therapeutics, Inc. (HARP) Delisted | Sell (S) | −239,740 | -$4.91M | EDGAR |
| 2021-04-15 | Harpoon Therapeutics, Inc. (HARP) Delisted | Sell (S) | −192,780 | -$3.89M | EDGAR |
| 2021-04-13 | Harpoon Therapeutics, Inc. (HARP) Delisted | Sell (S) | −154,640 | -$3.39M | EDGAR |